Rossell Techsys Q2 FY27: Consol PAT +70% YoY to ₹9.66 Cr, Margins Still Trail Guidance
PAT +70.39% YoY · revenue +48.36% · margins expanding
₹185.7 Cr
+48.36% YoY
₹9.66 Cr
+70.39% YoY
5.1%
+0.6pp YoY
₹2.56
Rossell Techsys' consolidated revenue rose 48.4% YoY to ₹185.70 Cr (up 20.2% QoQ from ₹154.46 Cr) and consolidated PAT climbed 70.4% YoY to ₹9.66 Cr (up 35.4% QoQ from ₹7.14 Cr), with basic EPS at ₹2.56. Both lines grew strongly in absolute terms, but the pace is decelerating against the company's own bar: Q1 FY27 revenue had grown ~78% YoY, and management's FY27 guidance called for a repeat of FY26's 87% revenue growth — H1 FY27 revenue is up only 60.2% YoY (₹340.16 Cr vs ₹212.39 Cr), so the growth trajectory is running behind the guided pace. No formal Street consensus could be found for this quarter (the stock carries little to no analyst coverage), so vsStreet is unknown rather than inferred.
Q2 FY-2027 vs prior quarters
Margins improved YoY but slipped sequentially and remain well short of guidance. OPM (EBITDA/revenue) was 13.78% versus 12.01% a year ago (+177 bps YoY) but down from 14.36% in Q1 FY27 (-58 bps QoQ); NPM was 5.10% versus 4.50% YoY and 4.58% QoQ. Management's prior concall guidance was explicit — EBITDA margins returning to a 17-22% band as investment benefits materialize — and the quarter's 13.78% print remains well below that range. Part of the squeeze sits below the operating line: finance cost jumped 129% YoY to ₹11.44 Cr (from ₹4.99 Cr) as total borrowings rose to ₹450.23 Cr from ₹409.41 Cr at FY26-end, funding the inventory and receivables build (inventories up to ₹386.44 Cr, trade receivables to ₹145.22 Cr) that accompanies the revenue ramp.
The stock went into the print at ₹1,415, down 12.8% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records.
Management guides for a repeat of FY26's 87% revenue growth in FY27, driven by a 300-400% expansion in the semiconductor and space segments. EBITDA margins are expected to improve and return to the 17% to 22% range as the benefits of recent investments are realized. The company is actively pursuing a QIP to fund signif
— This quarter: missed
The quarter was bookended by financing activity consistent with the guided capacity-expansion plan: the board allotted 25.7 lakh preferential shares for ₹300 Cr on November 4, 2026, which lifted SBI Mutual Fund's stake to 5.75%, following EGM approval in September. Standalone and consolidated results tell the same story (PAT ₹9.42 Cr vs ₹9.66 Cr, a sub-3% gap), so there's no material standalone/consolidated divergence to flag. The prior concall tone (May 2026) was confidently bullish on a 300-400% semiconductor/space segment expansion driving the FY27 growth guidance; this quarter's print confirms strong absolute growth and order execution but does not yet confirm the margin or growth-rate trajectory management laid out.
W1
Margin recovery toward the guided 17-22% OPM band — Q2 FY27 OPM at 13.78% remains 320-820 bps short
W2
FY27 revenue growth pace vs the guided 87% repeat of FY26 — H1 run-rate is 60.2% YoY, needing H2 acceleration (semiconductor/space ramp) to close the gap
W3
Deployment of the ₹300 Cr preferential capital (allotted Nov 4, 2026) into capacity expansion and its effect on finance costs/leverage, which rose 129% YoY this quarter
Clean typed filing (unaudited, limited-review). All figures converted from ₹ Lakh. No exceptional items in current or year-ago quarter, so raw and adjusted PAT growth are identical. Consolidated includes one wholly-owned US subsidiary, Rossell Techsys Inc.; standalone vs consolidated PAT differ by ~2.5%, not a material divergence.
Record growth masks margin miss; semicon claim overstated
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Revenue/PAT targets hit. Margin guidance unmet (15.6% vs 17–22%). FY27 numeric guide withdrawn/hedged despite being mid-year.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue & PAT growth (+48%/+70% YoY) and record order book signal structural upside in semiconductors & space. However, EBITDA margin at 15.6% lags prior 17–22% and new 18–23% targets; semicon growth claim (3–4x) contradicted by actual ~40% YoY delivery. FY27 guidance hedged mid-year. Key risk: interest costs (~equal to PAT) remain unresolved until Q3.
₹185.7 Cr
Revenue · +48.4% YoY₹9.7 Cr
Reported PAT · +70.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Highest ever quarterly revenue of ₹185.56 Cr
METDelivered ₹185.7 Cr, claim precise match
3–4x growth in semiconductors and space segments
OVERSTATEDNon-aero segment (mostly semicon/space) grew ~40% YoY: ₹100 Cr last year to ₹140 Cr H1 this year
EBITDA margins on track to 18–23% range
MISSQ2 EBITDA ₹29 Cr on ₹185.7 Cr revenue = 15.6%, below 17–22% prior guidance and below 18–23% new target
Operating leverage and scale benefits delivering
OVERSTATEDRevenue +48% YoY but margins compressed from prior guidance; leverage claim premature
Inventory efficiency: 7.98 months (Q2 FY26) → 6.67 months (Q2 FY27)
METStated improvement confirmed; targets 4-month inventory in 24 months
Fresh orders ₹430 Cr and bids ₹1,350 Cr in H1
METStated; no contradicting data
Earnings quality
What changed since the last call
Semicon customer base expanded
UpgradeNow partnering with two 'very large respected multinationals' in semicon vs prior single customer; on track for 3–4x segment growth over time
EBITDA margin guidance revised upward
UpgradePrior target 17–22%, now reaffirmed as 18–23%; Q2 actual 15.6% implies catch-up still needed but management confident on scale
Capital structure strengthened
Upgrade₹300 Cr QIP completed; balance sheet improved, working capital limits to be repaid, reducing interest burden from ~₹9.7 Cr (Q2)
FY27 numeric guidance withdrawn
NeutralPrior call: 87% FY27 revenue growth, 300–400% semicon/space expansion. This call: No FY27 number; H1 at 60% growth; managed expectations to Q3/Q4 seasonality
The Q&A
Analysts pressed hard on: (1) margin trajectory (Nisarg Shah) — management reaffirmed 18–23% but current 15.6% prompted skepticism. (2) Semicon 3–4x growth claim (Darshil Jhaveri) — management cited ₹140 Cr H1 (40% YoY) but didn't address shortfall. (3) FY27 guidance (Darshil, Nisarg) — management declined to quantify, citing Q3/Q4 seasonality. (4) Interest cost burden (Nitish Rana) — acknowledged as equal to PAT; promised Q3 relief but withheld specifics. Overall: Management deflected quantitative challenges onto Q3/Q4; tone hedge rather than under-deliver.
Margin trajectory — Nisarg Shah, Pkeday Investments
PartialYes, definitely. EBITDA and PBT margins are improving with scale. Target is 18–23% EBITDA; we're well on track to achieve that.
Revenue split — Nisarg Shah, Pkeday Investments
AnsweredNot currently. On ₹345 Cr H1, approximately ₹130–140 Cr was non-aerospace. Probably will be 50/50 by year-end.
Growth momentum — Nisarg Shah, Pkeday Investments
AnsweredYes, absolutely. Q3/Q4 have always been best quarters for Rossell. Expecting very good quarters; growth to continue for 12–16 quarters.
Inventory targets — Nisarg Shah, Pkeday Investments
AnsweredImproved from 7.8 months to 6.6 months. Internal target: three-turn inventory (4-month company) over next 24 months. Good improvement expected QoQ/YoY.
FY27 revenue guidance — Darshil Jhaveri, Crown Capital
DodgedCan't give exact forward-looking numbers. Q3/Q4 have always been best; should see same trend continue this year.
Semicon/space 3–4x growth — Darshil Jhaveri, Crown Capital
PartialOn track for that kind of growth. ₹140 Cr non-aero in H1 vs ₹100 Cr last year between semicon and space. Significant growth visible.
Order book execution — Darshil Jhaveri, Crown Capital
AnsweredTwo types: confirmed PO ₹910 Cr (2.5 years execution); strategic agreements ₹3,100 Cr (5-year execution).
Capital use — Nitish Rana, Individual Investor
AnsweredMix of both. Strengthen balance sheet and repay loans; also for future growth, operational excellence, and infrastructure.
Further fundraise — Nitish Rana, Individual Investor
AnsweredNot anytime soon. This ₹300 Cr will take company to different level; required for 3–4 year growth trajectory.
Interest cost reduction — Nitish Rana, Individual Investor
PartialMoney raised will repay working capital limits, reducing interest costs substantially; benefit visible in Q3 results. CFO noted 'significant portion' savings coming.
Semicon BD pipeline — Akash Jaiswal, Individual Investor
PartialGot another semicon customer; now with two very large respected multinationals. Significant growth visible; will pick up in Q3/Q4. Growth to continue 3+ years.
MRO business progress — Akash Jaiswal, Individual Investor
PartialAfter 14 years of wire harnesses, now have MRO capability. Talking to big companies to be MRO partner. Doing Boeing/US aftermarket work. Results in Q3/Q4, both India and international.
Guidance
No numeric FY27 target; implied continued growth Q3/Q4
LowPrior call: 87% FY27 growth. H1 at 60%. Management refused to quantify FY27; hedged to seasonality. Q3/Q4 'historically strongest.'
Non-aero/defense to reach 50% of total by FY27 end
MediumCurrently ~40% (₹140 Cr of ₹345 Cr H1). Semicon/space ramp in H2 expected to bridge gap. Specific 50/50 target stated.
EBITDA margin 18–23% (reaffirmed from prior 17–22%)
MediumQ2 actual 15.6%. Management cites scale benefits, but margin lag vs guidance unresolved. No timeline given for 18–23% achievement.
Interest cost reduction 'substantial,' visible Q3
LowInterest ~₹9.7 Cr (Q2 PAT level). ₹300 Cr capital raise to repay working capital limits; unquantified savings promised for Q3.
₹300 Cr capital raise deployed for growth capex, balance sheet, and operational excellence over 3–4 years
MediumNew facility (140k–210k sq ft) live early Q3; expansion option; workforce hiring ongoing. Allocation not itemized.
Risks the call surfaced
Guidance and margin credibility
MediumPrior guidance 17–22% EBITDA; Q2 delivers 15.6%. New target 18–23% stated but no timeline. Margin expansion claims challenged by analyst Q&A; management vague on path.
Semicon growth overstatement
MediumManagement targets 3–4x growth in semiconductors/space segment. H1 data shows non-aero segment (mostly semicon) grew ~40% YoY (₹100 Cr → ₹140 Cr). Analyst asked for specifics; management cited '2 large multinationals' but didn't address 40% vs 300–400% shortfall.
Interest burden and finance cost
HighQ2 finance costs (~₹9.7 Cr) equal reported PAT. Analyst flagged interest outgo ≈ net profit. Management promised 'substantial' reduction post-capital redeployment (₹300 Cr QIP), benefit visible in Q3. However, no quantification or detail on how much relief or when.
Customer concentration in semicon
MediumSemicon segment relies on 2 'very large respected multinationals.' New customer onboarded this quarter. Limited detail on diversification, order stability, or contract terms. If either customer reduces demand or qualifies alternatives, revenue impact could be material.
Execution risk on capacity ramp
MediumNew 140k–210k sq ft Aerospace Park facility expected to go live 'early Q3.' Expansion option to 210k sq ft not yet exercised. Semicon/MRO growth depends on successful commissioning and staffing. Delays or quality issues could impact growth cadence.
Management
Score 7/10. Articulate and structured; CEO, COO, CFO all present. Clear on strategy (semicon + space + MRO + A&D). However, declined to quantify FY27 revenue guidance despite being mid-year; vague on margin timeline and interest cost specifics. Hedged rather than committed. Strong H1 revenue and PAT growth (+48%, +70% YoY). But EBITDA margin at 15.6% vs 17–22% prior + 18–23% new target shows margin expansion lagging. Inventory efficiency genuine (7.98 → 6.67 months). Order book credible (₹910 Cr + ₹3.1k Cr pipeline). Semicon claim (3–4x) contradicted by ~40% YoY delivery.
1 · Q3 FY27 (Dec 2026)
New 140k–210k sq ft Aerospace Park facility goes live; margin benefit from capital redeployment; semicon/MRO traction expected
2 · Q3/Q4 FY27 (Q4 Mar 2027)
Historically strongest quarters; management expects semicon revenue to 'pick up significantly'; interest cost savings visible
3 · FY27 end (Mar 2027)
Revenue split target: 50/50 aerospace/non-aero (vs current ~60/40); margin trajectory to 18–23% EBITDA
Key risk: interest costs (~equal to PAT) remain unresolved until Q3.
Record revenue, compressed margins, semicon growth claim overstated
Q2 revenue hit a record ₹186 Cr (+48% YoY), driving 70% PAT growth, but EBITDA margin at 15.6% fell short of both prior 17–22% and new 18–23% guidance. Semicon growth claim of 3–4x contradicted by actual ~40% YoY delivery.
₹186 Cr
+48% YoY, record high
₹9.7 Cr
+70% YoY, but NPM 5.1%
15.6%
vs 17–22% prior, 18–23% new
₹345 Cr
+60% YoY
On the headline numbers, it looks like a blowout quarter. Revenue hit a record ₹186 crore, up 48% year-on-year. Profit surged 70%. But the call revealed the real story — and it's more complicated. The quarter proved two pieces of guidance wrong: the EBITDA margin target and the semicon growth claim. That's not a miss in execution; that's a miss in credibility.
Where the profit really comes from
PAT of ₹9.7 crore looks strong in isolation, but the profit margin tells the real story. Net profit margin is just 5.1% — compressed by finance costs. Management disclosed interest outgo of approximately ₹9.7 crore in Q2, almost exactly equal to reported PAT. That means underlying operating profit (before interest) is roughly ₹19.4 crore, not ₹9.7 crore. The company's profitability is being masked by debt. The good news: ₹300 crore was raised in a QIP (anchored by SBI MF and Kotak MF); management promised 'substantial' interest cost relief starting in Q3 from debt repayment. The bad news: until that happens, the profit story is understated.
The margin miss
EBITDA margin of 15.6% in Q2 is the core issue. In the prior call (FY26), management guided for 17–22% EBITDA margins 'as the benefits of recent investments are realized.' This call they revised upward to 18–23%, citing scale benefits. But Q2 actual of 15.6% falls 1.4 to 7.4 percentage points short of both targets. Analyst Nisarg Shah pressed directly: 'Previous calls guided 17–20% EBITDA margins; are we on that trajectory with operating leverage?' Management replied: 'Yes, definitely... we're well on track to achieve that' (the 18–23% target). But the numbers don't support that claim yet. At the current margin, delivering 18–23% by year-end would require a 240–450 basis point improvement in H2 — a jump management hasn't quantified or explained.
The semicon growth claim
The prior call (FY26) included bold guidance: '300–400% expansion in the semiconductor and space segments.' This quarter, that guidance quietly evaporated. When analyst Darshil Jhaveri asked directly, 'Were targeting 3–4x growth in space/semicon; how is that segment doing?' management said: 'On track for that kind of growth. ... ₹140 crore non-aero in H1 vs ₹100 crore last year between semicon and space.' That's a 40% year-on-year growth rate — nowhere close to 3–4x. Management cited two very large multinational OEM customers now on board (up from one), which is genuine progress. But the growth rate contradicts the prior guidance by an order of magnitude. Analysts didn't follow up; management didn't acknowledge the gap. That's the credibility issue.
What changed on this call
Semicon customer base expanded. Now partnering with two 'very large respected multinationals' in semicon (vs. prior single customer). This is genuine progress for diversification, but growth rate (40% YoY) falls far short of the 3–4x target.
Capital structure strengthened. ₹300 crore QIP completed successfully with strong institutional demand (SBI MF, Kotak MF anchor). Proceeds earmarked for debt repayment (working capital borrowings) and growth capex. Interest cost savings promised to be 'substantial' and visible in Q3.
New facility going live Q3. 140,000–210,000 sq ft Aerospace Park facility being inaugurated early next quarter, with expansion option to 210k sq ft. Designed to support semicon, non-defense, and MRO scaling. This is the capacity lever for the 50/50 split (aerospace / non-aero) targeted by year-end.
FY27 guidance hedged / withdrawn. Prior call: 87% FY27 revenue growth. This call: No numeric FY27 target given. H1 at 60% growth; management deflected quantification to 'Q3/Q4 historically strongest quarters.' Analyst Darshil Jhaveri pressed: 'Alluded to 80%+ growth previously; H1 at 60%; what is FY27 revenue guidance?' Management declined: 'Can't give exact forward-looking numbers.' That's a red flag when you're mid-year at 60% and the prior target was 87%.
Record quarterly revenue (₹186 Cr) and strong PAT growth (+70% YoY)
Order book ₹3.9k Cr (₹910 Cr confirmed + ₹3.1k Cr strategic); 12–16 quarter visibility
Semicon customer base expanded to 2 major OEMs; diversification underway
₹300 Cr capital raise completed; balance sheet de-risked
New facility (140k–210k sq ft) live Q3; MRO and semicon scaling capacity unlocked
Inventory efficiency improving (7.98 → 6.67 months; target 4 months)
EBITDA margin 15.6% vs 17–22% prior and 18–23% new target; repeated miss
Interest burden (~₹9.7 Cr) equals Q2 PAT; masks underlying operating profit
Semicon 3–4x growth claim contradicted by actual ~40% YoY delivery
FY27 guidance withdrawn mid-year despite 60% H1 growth (below 87% prior target)
Margin expansion and interest relief both unproven and unquantified
Risks, ranked by how much they should concern a holder
Margin expansion stalled
HighQ2 EBITDA margin 15.6% vs 18–23% target; no timeline given. If Q3/Q4 don't deliver 240–450 bps improvement, the bull case (scale benefits) is broken.
Interest burden unresolved until Q3
HighFinance costs ~₹9.7 Cr (= Q2 PAT) mask underlying profitability. Relief promised for Q3 but unquantified. If relief is <₹5 Cr, interest remains a headwind.
Semicon growth underperformance
Medium3–4x claim vs 40% YoY delivery. If growth stalls or customer concentration risk materializes (2 OEMs), the non-aero diversification thesis fails.
FY27 guidance credibility damaged
Medium87% prior target; 60% H1; no FY27 number given. If H2 growth doesn't re-accelerate, full-year misses and analyst confidence erodes.
Facility ramp-up execution
MediumNew 140k–210k sq ft facility live 'early Q3.' Delays or quality issues could stall semicon/MRO scaling.
How the street is positioned
The stock is at ₹1,429, down 15.87% from its all-time high of ₹1,699. That drawdown reflects market caution — and it's justified. The stock is near its 20-day moving average (₹1,430), holding above the 50-day (₹1,394) and well above the 200-day (₹1,018). RSI is 51.1 (neutral), suggesting no oversold bounce imminent. Volume is normal; no capitulation selling. Ownership is locked in: promoter stake 74.80% (unchanged for 6+ quarters), FII 1.68% (+8 bps quarter-on-quarter), DII 0.78% (-273 bps QoQ). The DII selling is worth noting — domestic institutions trimmed in Q1 FY27, suggesting they're waiting for margin proof before re-engaging. No insider selling near the highs, and no bulk/block deals in the past six months. The market has priced in margin and guidance concerns; a positive Q3 (facility ramp, margin improvement, interest relief) would likely re-rate the stock.
1 · Q3 EBITDA margin delivery
Is it 16–17% (modest improvement)? 18%+? The 18–23% target is only credible if Q3 shows material progression. A margin flat or down QoQ would be disqualifying.
2 · Interest cost reduction post-capital redeployment
Management promised 'substantial' Q3 relief from ₹300 Cr debt repayment. Quantify it: if interest drops to ₹5 Cr or less, the underlying PAT story strengthens. If it stays at ₹7–9 Cr, the profit recovery is weaker than promised.
3 · Facility ramp-up and semicon/MRO contribution
New 140k–210k sq ft facility live 'early Q3.' Did it come on-line? Is semicon revenue accelerating into H2? Any MRO wins or Boeing/US aftermarket traction materializing?
4 · Semicon 3–4x growth narrative
Does non-aero revenue jump in H2? If it stays at 40% YoY growth, the 3–4x claim is officially dead and customer concentration risk rises. If it accelerates to 60%+ YoY, the narrative survives (barely).
Rossell delivered record revenue and strong profit growth, but the call proved two key pieces of guidance wrong: the EBITDA margin target and the semicon growth rate. That's a pattern of credibility erosion, not a one-time miss. The stock's 15.87% drawdown from ATH is justified — the market is right to be cautious. The bull case (structural order book, semicon diversification, capacity unlock) is still intact, but it's now on probation. The bar for the next quarter is high: Q3 must deliver 18%+ EBITDA margin, visible interest cost relief, and a credible path to 50/50 split by year-end. If management executes, the stock re-rates. If margins stay compressed and guidance continues to slip, the correction deepens. Hold. The number to track from here is Q3 EBITDA margin — it's the tell.